WFC
50
-8
USB
62
-3
EQT
57
4
TROW
40
-2
HAS
63
-9
AEE
68
-3
DE
40
4
PNC
55
-2
CLX
48
2
TXT
65
-3
COF
64
-3
HP
48
-5
MMM
42
-3
HST
45
-4
ZTS
29
2
RSG
44
2
ADBE
46
2
GILD
68
8
UNM
43
-2
PX
73
-2
WFC
50
-8
USB
62
-3
EQT
57
4
TROW
40
-2
HAS
63
-9
AEE
68
-3
DE
40
4
PNC
55
-2
CLX
48
2
TXT
65
-3
COF
64
-3
HP
48
-5
MMM
42
-3
HST
45
-4
ZTS
29
2
RSG
44
2
ADBE
46
2
GILD
68
8
UNM
43
-2
PX
73
-2
Financhill
Back

Gitlab- Ordinary Shares - Class A Vs. Halozyme Therapeutics Inc. Industry Stock Comparison

Buy
65

GTLB
Gitlab- Ordinary Shares - Class A

Last Price:
$44.33
Seasonality Move:
3.72%
Buy
84

HALO
Halozyme Therapeutics Inc.

Last Price:
$67.29
Seasonality Move:
7.14%
Buy
65
Gitlab- Ordinary Shares - Class A (GTLB) is a Buy

Is Gitlab- Ordinary Shares - Class A a Buy, Sell or Hold?

  • The current Gitlab- Ordinary Shares - Class A [GTLB] share price is $44.28. The Score for GTLB is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • GTLB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
84
Halozyme Therapeutics Inc. (HALO) is a Buy

Is Halozyme Therapeutics Inc. a Buy, Sell or Hold?

  • The current Halozyme Therapeutics Inc. [HALO] share price is $67.27. The Score for HALO is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

GTLB Stock Price Chart

What is Gitlab- Ordinary Shares - Class A's stock price today?

  • The Gitlab- Ordinary Shares - Class A share price today is $44.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics Inc.'s stock price today?

  • The Halozyme Therapeutics Inc. share price today is $67.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.05 Buy
Relative Strength Index (14 RSI): 52.54 Buy
Chaikin Money Flow: 5212504 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.27 - 46.43) Buy
Bollinger Bands (100): (42.21 - 48.71) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.1 Buy
Relative Strength Index (14 RSI): 80.45 Buy
Chaikin Money Flow: 1409658 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.16 - 63.2) Buy
Bollinger Bands (100): (53.5 - 62.4) Buy

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.33 Buy
20-day SMA: 43.94 Buy
50-day SMA: 44.21 Buy
200-day SMA: 53.44 Sell
8-day EMA: 40.64 Buy
20-day EMA: 31.79 Buy
50-day EMA: 18.21 Buy
200-day EMA: 5.57 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.02 Buy
20-day SMA: 60.89 Buy
50-day SMA: 57.07 Buy
200-day SMA: 56.02 Buy
8-day EMA: 62.52 Buy
20-day EMA: 47.62 Buy
50-day EMA: 26.85 Buy
200-day EMA: 8.14 Buy

Gitlab- Ordinary Shares - Class A Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.12 per share.

Halozyme Therapeutics Inc. Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, an increase next quarter of $0.08 per share, an increase this year of $2.06 per share, and an increase next year of $1.39 per share.

Gitlab- Ordinary Shares - Class A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):